Edited by Peter Hillerberg2 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Q3 earnings season moved into top gear Monday. UNH and JNJ both reported this morning, giving healthcare investors an early read on the quarter. BAC follows Tuesday before the bell. SCHW and BNY report Wednesday. The week carries more than 380 companies across the US and Europe, with financials dominating the early schedule.
KR dominated Monday's tape for a different reason. Bloomberg reported the grocer plans to cut 37% of its corporate workforce over three years, about 3,000 roles. Put options surged on the news. Short interest already stood at 4.7 days to cover heading into the announcement.
Wells Fargo made a striking double move on software. Analyst Michael Turrin cut ADBE two notches from Buy to Sell, lowering his target to $225 from $270. He simultaneously upgraded TYL from Hold to Buy, lifting his target to $400 from $335.
The MSCI November review ranking date falls on 19 October, leaving just one week for several names to fight off deletion. Zalando SE sits 51% likely to exit MSCI World, trading 7.2% below the survival line of 25.52 EUR. Flutter Entertainment faces a 29% deletion probability with $601M of potential forced selling at stake. Charter Communications carries a 65% deletion probability. The biggest potential flow runs the other way: MRNA sits 75% above the MSCI entry line, with ORTEX forecasting an 81% chance of addition and $3.3B of forced buying if confirmed on 11 November.
Ireland's battery-electric car licensings jumped 54% year-on-year in September 2026, reaching 3,074 vehicles. Total Irish car sales hit 7,326, the largest September on record since 2014. Austrian registrations reached 28,968, the largest September in eight years. On the energy side, an XEL reactor recorded output 10.0 standard deviations below its own history on 11 October, according to ORTEX nuclear output data. The stock carries 8.2 days to cover and a short score of 51.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
